Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Journal of Neurosurgery|July 24, 2002
Acetazolamide therapy for symptomatic plateau waves in patients with brain tumors. Report of three casesChristopher J Watling, J Gregory Cairncross
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trialWarren P Mason, J Gregory Cairncross
Cancer Research|January 20, 2007
O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cellsMichael D Blough, Magdalena C Zlatescu, J Gregory Cairncross
Cancer Journal (Sudbury, Mass.)|September 4, 2003
Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype?Donna Senger, J Gregory Cairncross, Peter A J Forsyth
Journal of Neuro-Oncology|September 30, 2005
Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatinG Wei Xu, Joe S Mymryk, J Gregory Cairncross
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Influence of unrecognized molecular heterogeneity on randomized clinical trialsRebecca A Betensky, David N Louis, J Gregory Cairncross
Biostatistics (Oxford, England)|August 20, 2003
Analysis of a molecular genetic neuro-oncology study with partially biased selectionRebecca A Betensky, David N Louis, J Gregory Cairncross
International Journal of Cancer|April 1, 2005
Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomideG Wei Xu, Joe S Mymryk, J Gregory Cairncross
Statistics in Medicine|May 4, 2007
Tests of association under misclassification: application to histological sampling in oncologyRebecca A Betensky, David N Louis, J Gregory Cairncross
Pageof 9